News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Telo Genomics Closes Second and Final Tranche of Convertible Debentures Financing
March 9, 2026
·
5 min read
Press Releases
OS Therapies Announces FDA OST-HER2 Type D Meeting Elevated to Type B Pre-BLA Meeting
March 9, 2026
·
5 min read
Press Releases
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
March 9, 2026
·
7 min read
Press Releases
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
March 6, 2026
·
5 min read
Press Releases
Phio Pharmaceuticals Reports 2025 Year-End Financial Results and Business Update
March 5, 2026
·
8 min read
Press Releases
Biohacking Index Spotlights Leaders from Functional Longevity Summit
March 5, 2026
·
1 min read
Press Releases
BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy
March 5, 2026
·
3 min read
Press Releases
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
March 5, 2026
·
5 min read
Press Releases
Octane Medical Group Signs Agreement to Acquire Lonza’s Personalized Medicine Business
March 4, 2026
·
3 min read
Press Releases
Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval
March 4, 2026
·
4 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us